Iveda Solutions Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $4.6M-24.0% YoYTTM through 30 Jun 2026
Net Income -$3.2MTTM through 30 Jun 2026
Free Cash Flow -$2.9MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 24.1% |
| EBITDA Margin | -68.1% |
| Operating Margin | -61.1% |
| Net Margin | -69.2% |
Returns
-66.9%ROE
-49.8%ROA
Balance Sheet Health
Debt / Equity0.12x
Current Ratio4.86x
Net Debt-$4.6Mnet cash position
Cash & Equivalents$4.8M
Quality Metrics
Altman Z-Score-9.99
Piotroski F-Score5 / 9
FCF Margin-64.2%
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $5.3M
Diluted EPS-$0.53TTMFY2025: $-0.88
Dividend
No dividend
Capital Allocation
R&D Spend$214.1K
Capex Intensity0.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Taiwan-based segment (Iveda Taiwan) | $4.5M | ||
| U.S.-based segment | $792K |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.